Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor

Abstract

Pre-exposure oral prophylaxis with antiviral drugs is a potential method for preventing transmission of human immunodeficiency virus type 1 (HIV-1). We show that oral delivery of CMPD167, a small molecule that binds to the CCR5 coreceptor, for 10–14 d can protect a substantial proportion of macaques from vaginal infection with a CCR5-using virus (SHIV-162P3). The macaques that became infected despite receiving CMPD167 had reduced plasma viremia levels during the earliest stages of infection.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1: Plasma viral load in SHIV-162P3-infected animals.

References

  1. Youle, M. & Wainberg, M.A. AIDS 17, 937–938 (2003).

    Article  Google Scholar 

  2. Shattock, R.J. & Moore, J.P. Nat. Rev. Microbiol. 1, 25–34 (2003).

    Article  CAS  Google Scholar 

  3. AIDS Vaccine Advocacy Coalition. Will a pill a day prevent HIV? Anticipating the results of the tenofovir “PREP” trials. A special publication of the AIDS Vaccine Advocacy Coalition (AVAC). http://www.avac.org/pdf/tenofovir.pdf. (2005).

  4. Seibert, C. & Sakmar, T.P. Curr. Pharm. Des. 10, 2041–2062 (2004).

    Article  CAS  Google Scholar 

  5. Barber, C.G. Curr. Opin. Investig. Drugs 5, 851–861 (2004).

    CAS  PubMed  Google Scholar 

  6. Watson, C., Jenkinson, S., Kazmierski, W. & Kenakin, T.P. Mol. Pharmacol. 67, 1268–1282 (2005).

    Article  CAS  Google Scholar 

  7. Kuhmann, S.E. et al. J. Virol. 78, 2790–2807 (2004).

    Article  CAS  Google Scholar 

  8. Veazey, R.S. & Lackner, A.A. Nat. Med. 11, 469–470 (2005).

    Article  CAS  Google Scholar 

  9. Veazey, R.S. et al. Nature, published online 30 October 2005 (10.1038/nature04055).

  10. Veazey, R.S. et al. J. Exp. Med. 198, 1551–1562 (2003).

    Article  CAS  Google Scholar 

  11. Wolinsky, S.M. et al. Virology 328, 19–29 (2004).

    Article  CAS  Google Scholar 

  12. Tsai, C.C. et al. Science 270, 1197–1199 (1995).

    Article  CAS  Google Scholar 

  13. Tsai, C.C. et al. J. Virol. 72, 4265–4273 (1998).

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Marx, P.A. et al. Nat. Med. 2, 1084–1089 (1996).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John P Moore.

Ethics declarations

Competing interests

Martin S. Springer is an employee of Merck Inc., but this company did not fund the study.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Veazey, R., Springer, M., Marx, P. et al. Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor. Nat Med 11, 1293–1294 (2005). https://doi.org/10.1038/nm1321

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1321

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing